Clinical Trials Browser

Phase 2 × Depression × Clear all

NCT07336238 2026-05-26

Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

Phase 2 Recruiting

Anxiety Disorders, Depression, Neoplasm Metastasis

NCT05947383 2026-05-06

2Dose

Phase 2 Active not recruiting

Depression, Depressive Disorder, Major, Neoplasms

NCT07002034 2026-05-06

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Phase 2 Recruiting

Adjustment Disorders, Amyotrophic Lateral Sclerosis, Anxiety Disorders, Depression, Multiple Sclerosis, Neoplasms, Idiopathic Pulmonary Fibrosis

NCT06200155 2026-04-16

Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy

Phase 2 Recruiting

Anxiety Disorders, Depression

NCT06801041 2026-04-16

TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

Phase 2 Recruiting

Anxiety Disorders, Depression, Neoplasms

NCT06266611 2025-08-01

ARCTiC

Phase 2 Recruiting

Anxiety Disorders, Depression, Pain

NCT06136546 2025-05-07

Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab

Phase 2 Recruiting

Depression, Depressive Disorder, Major, Inflammation, Cognitive Dysfunction

NCT02203552 2025-01-08

Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer

Phase 2 Completed

56 enrolled 9 charts

Anxiety Disorders, Breast Neoplasms, Depression

NCT05724849 2024-01-18

Venlafaxine for the Prevention of Depression in Patients With Head and Neck Cancer

Phase 2 Withdrawn

Depression, Head and Neck Neoplasms

NCT00979693 2023-12-26

Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV Melanoma

Phase 2 Withdrawn

Anxiety Disorders, Depression, Melanoma, Pain

NCT03944447 2022-06-02

OMNI-Can

Phase 2 Unknown

200,000 enrolled

Classical hematology

Chronic Traumatic Encephalopathy, Brain Injuries, Traumatic, COVID-19, Acquired Immunodeficiency Syndrome, Amyotrophic Lateral Sclerosis, Anemia, Sickle Cell, Anxiety Disorders, Autistic Disorder, Bipolar Disorder, Colitis, Ulcerative, Crohn Disease, Depression, Epilepsy, Fibromyalgia, Tourette Syndrome, Glaucoma, Hepatitis C, Sleep Initiation and Maintenance Disorders, Multiple Sclerosis, Opioid-Related Disorders, Neoplasms, Parkinson Disease, Seizures, Stress Disorders, Post-Traumatic, Inflammatory Bowel Diseases, Coronavirus Infections, Severe Acute Respiratory Syndrome, Chronic Pain

NCT03410446 2022-05-06

Study of Ketamine for Depression in Cancer Patients Receiving Palliative Care

Phase 2 Completed

Depression, Neoplasms

NCT01466270 2021-10-20

Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction

Phase 2 Completed

62 enrolled 12 charts

Anxiety Disorders, Breast Neoplasms, Cognition Disorders, Depression, Fatigue, Sleep Wake Disorders

NCT00465595 2018-07-19

Psychopharmacology of Psilocybin in Cancer Patients

Phase 2 Completed

56 enrolled 8 charts

Anxiety Disorders, Depression, Neoplasms

NCT00068458 2017-12-19

Survival TRaining for ENhancing Total Health (STRENGTH)

Phase 2 Completed

Body Weight Changes, Breast Neoplasms, Depression

NCT03205033 2017-07-02

Melatonin as a Circadian Clock Regulator, Neuromodulator and Myelo-protector in Adjuvant Breast Cancer Chemotherapy

Phase 2 Completed

Breast Neoplasms, Depression, Pain, Sleep Disorders, Circadian Rhythm

NCT03063931 2017-02-27

Pain and Magnesium

Phase 2 Unknown

Anxiety Disorders, Breast Neoplasms, Depression, Pain

NCT00005850 2016-07-04

Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Phase 2 Completed

Adenocarcinoma of Lung, Anxiety Disorders, Carcinoma, Non-Small-Cell Lung, Depression, Fatigue, Lung Neoplasms

NCT01680172 2016-02-29

Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer

Phase 2 Terminated

5 enrolled 6 charts

Anxiety Disorders, Depression, Neoplasms

NCT02650544 2016-01-08

Efficacy and Safety Analyses of Mirtazapine in NSCLC Patients With Depression

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Depression

NCT02468050 2015-06-10

Study of Exercise to Manage Distress During Breast Screening

Phase 2 Completed

Anxiety Disorders, Breast Neoplasms, Depression, Disease, Motor Activity

NCT01748734 2015-06-04

Cognitive Therapy in Reducing Depression in Patients With Cancer

Phase 2 Completed

Depression

NCT01510236 2015-05-28

U-CARE:TeenCan

Phase 2 Withdrawn

Anxiety Disorders, Depression, Neoplasms

NCT00706290 2014-06-06

Brief CBT for Anxiety and Advanced Cancer

Phase 2 Completed

Anxiety Disorders, Depression, Neoplasm Metastasis, Neoplasms

NCT00069927 2014-02-03

Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression

Phase 2 Terminated

Depression, Neurotoxicity Syndromes

NCT00424203 2013-09-04

Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery

Phase 2 Completed

Breast Neoplasms, Depression, Malnutrition

NCT00851669 2013-07-16

MEADOW/Bridge

Phase 2 Completed

Alcoholism, Depression, Multiple Endocrine Neoplasia Type 1

NCT01507571 2012-01-11

DignityDK

Phase 2 Completed

Depression, Neoplasms

NCT00774813 2008-10-17

Nexalin Therapy for the Treatment of Depressive Symptoms

Phase 2 Completed

Anxiety Disorders, Depression, Lymphoma, Follicular

NCT00186511 2006-12-05

Expanding Rural Access: Distance Delivery of Support

Phase 2 Completed

Breast Neoplasms, Depression, Stress Disorders, Post-Traumatic